Evidence map›Paper›PMID 40092589›Full record

ArticleOutbreak, surveillance, investigation & response (OSIR) journal2023

Results and Policy Implications of a COVID-19 Vaccine Post-introduction Evaluation in Thailand, May 2022.

Chawetsan Namwat, Prabda Praphasiri, Chakrarat Pittayawonganon, Kriengkrai Prasert, Sutthichai Nakphook, Thanawadee Thantithaveewat, Aree Moungsookjareoun, Monica Fleming, Margaret Hercules, Ann C Moen and 6 more

Abstract read
In one paragraph

Article in Outbreak, surveillance, investigation & response (OSIR) journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chawetsan NamwatDivision of Disease Control in Emergency Situations, Department of Disease Control, Ministry of Public Health, Thailand.
Prabda PraphasiriThailand MOPH-US CDC Collaboration, Thailand.
Chakrarat PittayawonganonDivision of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand.
Kriengkrai PrasertFaculty of Public Health, Kasetsart University, Chalermprakiat Sakon Nakhon Province Campus, Thailand.
Sutthichai NakphookFaculty of Public Health, Kasetsart University, Chalermprakiat Sakon Nakhon Province Campus, Thailand.
Thanawadee ThantithaveewatDepartment of Disease Control, Ministry of Public Health, Thailand.
Aree MoungsookjareounWHO Country Office, Thailand.
Monica FlemingU.S. Centers for Disease Control and Prevention, USA.
Margaret HerculesU.S. Centers for Disease Control and Prevention, USA.
Ann C MoenU.S. Centers for Disease Control and Prevention, USA.
Anthony MountsTask Force for Global Health, USA.
Patranuch SapchookulThailand MOPH-US CDC Collaboration, Thailand.
Darunee DitsungnoenThailand MOPH-US CDC Collaboration, Thailand.
James D HeffelfingerThailand MOPH-US CDC Collaboration, Thailand.
William W DavisThailand MOPH-US CDC Collaboration, Thailand.
Sopon IamsirithawornDepartment of Disease Control, Ministry of Public Health, Thailand.

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

Thailand initiated a COVID-19 vaccine campaign in February 2021, and by March 2022, approximately 72% of residents over 5 years of age had received two doses of vaccine. We evaluated Thailand's COVID-19 vaccine campaign in Bangkok and in four additional provinces using the World Health Organization COVID-19 post-immunization evaluation (cPIE) protocol. Strengths of the vaccine program included close coordination between different levels and sectors of the Royal Thai Government, close community engagement, and use of national data systems. Areas of the campaign that needed interventions included reviewing cold chain practices, standardizing data forms and addressing bottlenecks in data systems.

Indexed as

campaigncPIEevaluationSARS CoV-2Thailandvaccination

Identifiers

PMID40092589
PMCPMC11907278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.